Once-Monthly GLP-1 Injection Shows Significant Weight Loss Without Plateau in non diabetics in Phase 2 trial
Pfizer reported that its ultra-long-acting, once-monthly GLP-1 injectable achieved up to 12.3% placebo-adjusted weight loss by week 28, with no weight-loss plateau, in adults with obesity or overweight without type…
